Myriad Genetics Inc (MYGN) Stock Price, Quote & AI Analysis

Live MYGN stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Myriad Genetics Inc.

TradeVae provides AI-driven analysis and real-time market intelligence for Myriad Genetics Inc (MYGN), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

MYGN
Myriad Genetics Inc
real-time
$0.00 +0.00 (+0.00%)
Open
5.230000
High
5.370000
Low
5.030000
Volume
915,632
VWAP
-
Market Cap
$533,182,489.84
52W Range
$3.76 - $15.47
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
May 4, 2026 Q1
After Hours
Revenue Estimate: $214,652,512.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Myriad Genetics Inc's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Myriad Genetics Inc Overview

Company information

Company Overview

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Company Details
Market Cap
$476.79M
Shares Outstanding
93,213,726
Weighted Shares Outstanding
93,213,722
CEO
Samraat S Raha
Address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Employees
2,700
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Myriad Genetics Inc Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...